Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CCR1 | P32246 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26466724 | 0.96 | MAOB (0.38) | MAOBALDH1A1L3MBTL1OPRM1OPRD1 | |
| SCHEMBL26464703 | 0.94 | NPSR1 (0.39) | MAOBALDH1A1L3MBTL1OPRM1OPRD1 | |
| SCHEMBL26465349 | 0.92 | NPSR1 (0.40) | MAOBALDH1A1L3MBTL1OPRM1OPRD1 | |
| SCHEMBL20621628 | 0.92 | NPSR1 (0.40) | MAOBALDH1A1L3MBTL1OPRM1OPRD1 | |
| SCHEMBL19388380 | 0.88 | NR1I2 (0.41) | MAOBALDH1A1L3MBTL1OPRM1OPRD1 | |
| SCHEMBL12469514 | 0.83 | MAOB (0.44) | MAOBALDH1A1L3MBTL1CCR1TSHR | |
| SCHEMBL21085459 | 0.82 | MAOB (0.39) | MAOBALDH1A1L3MBTL1CCR1TSHR | |
| SCHEMBL19286065 | 0.78 | NPSR1 (0.41) | MAOBALDH1A1L3MBTL1OPRM1OPRD1 | |
| SCHEMBL27719352 | 0.76 | MAOB (0.40) | MAOBALDH1A1L3MBTL1TSHRKMT2A | |
| SCHEMBL31530729 | 0.74 | MAOB (0.39) | MAOBALDH1A1L3MBTL1CCR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| US-20230013344-A1 | MTORC MODULATORS AND USES THEREOF | EVOTEC (FRANCE) SAS (FR) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | MAOB 4449/4885ALDH1A1 4766/4885L3MBTL1 1721/4885 |
| US-20230013344-A1 | MTORC MODULATORS AND USES THEREOF | MTOR, RICTOR, RPTOR | MAOB 4449/4885ALDH1A1 4766/4885L3MBTL1 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.